Cyproterone represents a potent anti-androgen therapeutic for androgen management. Binding directly to hormone receptors prevents downstream signaling, facilitating control over specific endocrine-driven conditions internally.
Cyproterone belongs to the class of synthetic steroidal anti-androgens. It is designed to block the effects of male hormones and, at higher doses, to reduce the production of these hormones. In Singapore, this active compound is most commonly encountered in combined hormonal products such as Diane 35, which pairs cyproterone acetate with ethinylestradiol. The ingredient’s primary therapeutic role is to manage conditions that are driven by excess androgen activity.
Cyproterone appears in tablet form within several brand-name and generic options. The most recognizable preparation is Diane 35, a fixed-dose combination that contains both cyproterone acetate and ethinylestradiol. Apart from this, the compound may be found in other oral preparations prescribed for similar hormone-related indications. In Singapore, both branded and generic versions are regulated by the Health Sciences Authority and are supplied through licensed pharmacies.
These applications are typically considered for adult women who exhibit signs of heightened androgen activity.
Cyproterone interferes with androgen receptors, preventing natural male hormones such as testosterone from binding and activating these sites. At the same time, it exerts a modest suppressive effect on the pituitary gland, which leads to a slight decrease in overall hormone production. This dual action helps to balance the hormonal environment without completely shutting down androgen function.
These effects are usually short-lived and resolve without medical intervention.
For a complete list of potential interactions, refer to the individual medication’s detailed information.
Store tablets in a cool, dry place away from direct sunlight. Typical treatment courses vary; some users take the medication for several months to address acne, while others may continue longer to manage chronic hirsutism. The duration and dosage differ between products like Diane 35 and other cyproterone-containing tablets, so it is important to follow the specific guidance that accompanies each medication.
This article provides an educational snapshot of cyproterone as an active substance and does not substitute professional guidance. Individual medicines containing this compound, such as Diane 35, differ in strength, formulation, and usage instructions. The author assumes no liability for clinical outcomes based on this overview. Readers should examine the labeling of their specific product and seek guidance from a qualified healthcare professional for personalized information.
